Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 23, 2025 Filed Jun 25, 2025 21:45 UTC |
WELCH DANIEL GDirector
|
GrantShare Option (right to buy) · Derivative | 51,804 | $0.00 Strike: $7.37 | $0.00 |
DisclosureSEC source: 0001415889-25-018213 · form4-06252025_050601.xml · derivative · entry 1 WELCH DANIEL G · CIK 0001206199 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,804 Underlying: Ordinary Shares · 51,804 shares Expires 2035-06-22 F1 · derivative.exercise_price: The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's American Depositary Shares ("ADSs"). F2 · derivative.exercise_date: The shares vest in equal monthly installments over the 12 months following June 23, 2025, provided that the grant will in any case be fully vested on the date immediately prior to the date of the Issuer's 2026 annual shareholder meeting, F3 · derivative.underlying_shares: The Ordinary Shares of the Issuer may be represented by ADSs. Each ADS represents three Ordinary Shares of the Issuer. Read SEC document |
| June 23, 2025 Filed Jun 25, 2025 21:45 UTC |
LOVE TED WDirector
|
GrantShare Option (right to buy) · Derivative | 51,804 | $0.00 Strike: $7.37 | $0.00 |
DisclosureSEC source: 0001415889-25-018217 · form4-06252025_050609.xml · derivative · entry 1 LOVE TED W · CIK 0001188919 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,804 Underlying: Ordinary Shares · 51,804 shares Expires 2035-06-22 F1 · derivative.exercise_price: The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's American Depositary Shares ("ADSs"). F2 · derivative.exercise_date: The shares vest in equal monthly installments over the 12 months following June 23, 2025, provided that the grant will in any case be fully vested on the date immediately prior to the date of the Issuer's 2026 annual shareholder meeting, F3 · derivative.underlying_shares: The Ordinary Shares of the Issuer may be represented by ADSs. Each ADS represents three Ordinary Shares of the Issuer. Read SEC document |
| June 23, 2025 Filed Jun 25, 2025 21:45 UTC |
DOBMEIER ERICDirector
|
GrantShare Option (right to buy) · Derivative | 51,804 | $0.00 Strike: $7.37 | $0.00 |
DisclosureSEC source: 0001415889-25-018215 · form4-06252025_050605.xml · derivative · entry 1 DOBMEIER ERIC · CIK 0001202785 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,804 Underlying: Ordinary Shares · 51,804 shares Expires 2035-06-22 F1 · derivative.exercise_price: The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's American Depositary Shares ("ADSs"). F2 · derivative.exercise_date: The shares vest in equal monthly installments over the 12 months following June 23, 2025, provided that the grant will in any case be fully vested on the date immediately prior to the date of the Issuer's 2026 annual shareholder meeting, F3 · derivative.underlying_shares: The Ordinary Shares of the Issuer may be represented by ADSs. Each ADS represents three Ordinary Shares of the Issuer. Read SEC document |
| June 23, 2025 Filed Jun 25, 2025 21:45 UTC |
TETLOW SHARONDirector
|
GrantShare Option (right to buy) · Derivative | 51,804 | $0.00 Strike: $7.37 | $0.00 |
DisclosureSEC source: 0001415889-25-018214 · form4-06252025_050603.xml · derivative · entry 1 TETLOW SHARON · CIK 0001328565 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,804 Underlying: Ordinary Shares · 51,804 shares Expires 2035-06-22 F1 · derivative.exercise_price: The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's American Depositary Shares ("ADSs"). F2 · derivative.exercise_date: The shares vest in equal monthly installments over the 12 months following June 23, 2025, provided that the grant will in any case be fully vested on the date immediately prior to the date of the Issuer's 2026 annual shareholder meeting, F3 · derivative.underlying_shares: The Ordinary Shares of the Issuer may be represented by ADSs. Each ADS represents three Ordinary Shares of the Issuer. Read SEC document |
| June 23, 2025 Filed Jun 25, 2025 21:45 UTC |
Russell Angus C.Director
|
GrantShare Option (right to buy) · Derivative | 42,833 | $0.00 Strike: $7.37 | $0.00 |
DisclosureSEC source: 0001415889-25-018218 · form4-06252025_050611.xml · derivative · entry 1 Russell Angus C. · CIK 0001534002 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,833 Underlying: Ordinary Shares · 42,833 shares Expires 2035-06-22 F1 · derivative.exercise_price: The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's American Depositary Shares ("ADSs"). F2 · derivative.exercise_date: The shares vest in equal monthly installments over the 12 months following June 23, 2025, provided that the grant will in any case be fully vested on the date immediately prior to the date of the Issuer's 2026 annual shareholder meeting, F3 · derivative.underlying_shares: The Ordinary Shares of the Issuer may be represented by ADSs. Each ADS represents three Ordinary Shares of the Issuer. Read SEC document |
| June 23, 2025 Filed Jun 25, 2025 21:45 UTC |
Waldstreicher JoanneDirector
|
GrantShare Option (right to buy) · Derivative | 51,804 | $0.00 Strike: $7.37 | $0.00 |
DisclosureSEC source: 0001415889-25-018216 · form4-06252025_050607.xml · derivative · entry 1 Waldstreicher Joanne · CIK 0001962413 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,804 Underlying: Ordinary Shares · 51,804 shares Expires 2035-06-22 F1 · derivative.exercise_price: The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's American Depositary Shares ("ADSs"). F2 · derivative.exercise_date: The shares vest in equal monthly installments over the 12 months following June 23, 2025, provided that the grant will in any case be fully vested on the date immediately prior to the date of the Issuer's 2026 annual shareholder meeting, F3 · derivative.underlying_shares: The Ordinary Shares of the Issuer may be represented by ADSs. Each ADS represents three Ordinary Shares of the Issuer. Read SEC document |
| May 21, 2025 Filed Jul 3, 2025 17:15 UTC |
Coll Crespo BlasCHIEF MEDICAL OFFICER
|
GrantAmerican Depositary Shares · Derivative | 429 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-019354 · form4-07032025_050709.xml · derivative · entry 4 Coll Crespo Blas · CIK 0002037144 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,157 Underlying: Ordinary Shares · 1,287 shares Expires not disclosed F4 · derivative.exercise_price: Each ADS is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The ADSs have no expiration date. F5 · kind: Voluntary reporting of the acquisition of 429 ADSs by the Reporting Person on May 21, 2025 pursuant to the Issuer's Employee Share Purchase Plan. F4 · derivative.exercise_date: Each ADS is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The ADSs have no expiration date. F4 · derivative.expiration_date: Each ADS is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The ADSs have no expiration date. F1 · derivative.underlying: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents three Ordinary Shares of the Issuer. Read SEC document |
| May 21, 2025 Filed Jul 3, 2025 21:15 UTC |
Stevens Raymond CDirector · CHIEF EXECUTIVE OFFICER
|
GrantAmerican Depositary Shares · Derivative | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-019350 · form4-07032025_050702.xml · derivative · entry 5 Stevens Raymond C · CIK 0001698149 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,000 Underlying: Ordinary Shares · 3,000 shares Expires not disclosed F5 · derivative.exercise_price: Each ADS is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The ADSs have no expiration date. F6 · kind: Voluntary reporting of the acquisition of 1,000 ADSs by the Reporting Person on May 21, 2025 pursuant to the Issuer's Employee Share Purchase Plan. F5 · derivative.exercise_date: Each ADS is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The ADSs have no expiration date. F5 · derivative.expiration_date: Each ADS is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The ADSs have no expiration date. F1 · derivative.underlying: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents three Ordinary Shares of the Issuer. Read SEC document |
| May 21, 2025 Filed Jul 3, 2025 21:15 UTC |
Yoon JunCHIEF FINANCIAL OFFICER
|
GrantAmerican Depositary Shares · Derivative | 831 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-019351 · form4-07032025_050704.xml · derivative · entry 5 Yoon Jun · CIK 0001962414 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,946 Underlying: Ordinary Shares · 2,963 shares Expires not disclosed F5 · derivative.exercise_price: Each ADS is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The ADSs have no expiration date. F5 · derivative.exercise_date: Each ADS is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The ADSs have no expiration date. F5 · derivative.expiration_date: Each ADS is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The ADSs have no expiration date. F1 · derivative.underlying: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents three Ordinary Shares of the Issuer. Read SEC document |
| May 20, 2025 Filed Mar 5, 2026 18:20 UTC |
Hall AshleyChief Development Officer
|
GrantAmerican Depositary Shares · Derivative | 225 | $0.00 | $0.00 |
DisclosureSEC source: 0001801842-26-000002 · form4-03052026_060304.xml · derivative · entry 2 Hall Ashley · CIK 0001801842 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 225 Underlying: Ordinary Shares · 675 shares Expires not disclosed F3 · derivative.exercise_price: Each ADS is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The ADSs have no expiration date. F4 · kind: Voluntary reporting of the acquisition of 225 ADSs by the Reporting Person on May 20, 2025 pursuant to the Issuer's Employee Share Purchase Plan. F3 · derivative.exercise_date: Each ADS is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The ADSs have no expiration date. F3 · derivative.expiration_date: Each ADS is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The ADSs have no expiration date. F1 · derivative.underlying: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents three Ordinary Shares of the Issuer. Read SEC document |
| March 15, 2025 Filed Mar 18, 2025 20:45 UTC |
Coll Crespo BlasChief Medical Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 284,241 | $0.00 Strike: $7.02 | $0.00 |
DisclosureSEC source: 0001415889-25-008555 · form4-03182025_080313.xml · derivative · entry 2 Coll Crespo Blas · CIK 0002037144 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 284,241 Underlying: Ordinary Shares · 284,241 shares Expires 2035-03-14 F3 · derivative.exercise_price: The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's ADSs. F4 · derivative.exercise_date: 1/4th of the shares subject to the option shall vest March 1, 2026, and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each such vesting date. F1 · derivative.underlying: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ('ADSs"). Each ADS represents three Ordinary Shares of the Issuer. Read SEC document |
| March 15, 2025 Filed Mar 18, 2025 20:45 UTC |
Coll Crespo BlasChief Medical Officer
|
GrantOrdinary Shares | 116,988 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-008555 · form4-03182025_080313.xml · nonDerivative · entry 1 Coll Crespo Blas · CIK 0002037144 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 219,588 F1 · security: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ('ADSs"). Each ADS represents three Ordinary Shares of the Issuer. F2 · kind: Represents the grant of restricted stock units ("RSUs"), each of which represents a contingent right to receive one Ordinary Share of the Issuer. The RSUs vest 1/4th annually on each anniversary of March 1, 2025, subject to Reporting Person's continued service on such dates. Read SEC document |
| March 15, 2025 Filed Mar 18, 2025 20:45 UTC |
Hall AshleyChief Development Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 124,032 | $0.00 Strike: $7.02 | $0.00 |
DisclosureSEC source: 0001415889-25-008554 · form4-03182025_080311.xml · derivative · entry 2 Hall Ashley · CIK 0001801842 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 124,032 Underlying: Ordinary Shares · 124,032 shares Expires 2035-03-15 F3 · derivative.exercise_price: The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's ADSs. F4 · derivative.exercise_date: 1/4th of the shares subject to the option shall vest March 1, 2026, and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each such vesting date. F1 · derivative.underlying: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ('ADSs"). Each ADS represents three Ordinary Shares of the Issuer. Read SEC document |
| March 15, 2025 Filed Mar 18, 2025 20:45 UTC |
Hall AshleyChief Development Officer
|
GrantOrdinary Shares | 51,048 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-008554 · form4-03182025_080311.xml · nonDerivative · entry 1 Hall Ashley · CIK 0001801842 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 118,338 F1 · security: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ('ADSs"). Each ADS represents three Ordinary Shares of the Issuer. F2 · kind: Represents the grant of restricted stock units ("RSUs"), each of which represents a contingent right to receive one ordinary share of the Issuer. The RSUs vest 1/4th annually on each anniversary of March 1, 2025, subject to Reporting Person's continued service on such dates. Read SEC document |
| March 15, 2025 Filed Mar 19, 2025 00:45 UTC |
Stevens Raymond CDirector · CHIEF EXECUTIVE OFFICER
|
GrantEmployee Stock Option (right to buy) · Derivative | 826,890 | $0.00 Strike: $7.02 | $0.00 |
DisclosureSEC source: 0001415889-25-008550 · form4-03182025_080301.xml · derivative · entry 3 Stevens Raymond C · CIK 0001698149 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 826,890 Underlying: Ordinary Shares · 826,890 shares Expires 2035-03-14 F4 · derivative.exercise_price: The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's ADSs. F5 · derivative.exercise_date: 1/4th of the shares subject to the option shall vest March 1, 2026, and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each such vesting date. F1 · derivative.underlying: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ('ADSs"). Each ADS represents three Ordinary Shares of the Issuer. Read SEC document |
| March 15, 2025 Filed Mar 19, 2025 00:45 UTC |
Stevens Raymond CDirector · CHIEF EXECUTIVE OFFICER
|
GrantOrdinary Shares | 340,332 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-008550 · form4-03182025_080301.xml · nonDerivative · entry 1 Stevens Raymond C · CIK 0001698149 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,133,678 F1 · security: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ('ADSs"). Each ADS represents three Ordinary Shares of the Issuer. F2 · kind: Represents the grant of restricted stock units ("RSUs"), each of which represents a contingent right to receive one Ordinary Share of the Issuer. The RSUs vest 1/4th annually on each anniversary of March 1, 2025, subject to Reporting Person's continued service on such dates. Read SEC document |
| March 15, 2025 Filed Mar 19, 2025 00:45 UTC |
Ma YingliCHIEF TECHNOLOGY OFFICER
|
GrantEmployee Stock Option (right to buy) · Derivative | 155,040 | $0.00 Strike: $7.02 | $0.00 |
DisclosureSEC source: 0001415889-25-008553 · form4-03182025_080308.xml · derivative · entry 2 Ma Yingli · CIK 0001963664 · CHIEF TECHNOLOGY OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 155,040 Underlying: Ordinary Shares · 155,040 shares Expires 2035-03-15 F3 · derivative.exercise_price: The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's ADSs. F4 · derivative.exercise_date: 1/4th of the shares subject to the option shall vest March 1, 2026, and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each such vesting date. F1 · derivative.underlying: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ('ADSs"). Each ADS represents three Ordinary Shares of the Issuer. Read SEC document |
| March 15, 2025 Filed Mar 19, 2025 00:45 UTC |
Ma YingliCHIEF TECHNOLOGY OFFICER
|
GrantOrdinary Shares | 63,810 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-008553 · form4-03182025_080308.xml · nonDerivative · entry 1 Ma Yingli · CIK 0001963664 · CHIEF TECHNOLOGY OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,539 F1 · security: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ('ADSs"). Each ADS represents three Ordinary Shares of the Issuer. F2 · kind: Represents the grant of restricted stock units ("RSUs"), each of which represents a contingent right to receive one ordinary share of the Issuer. The RSUs vest 1/4th annually on each anniversary of March 1, 2025, subject to Reporting Person's continued service on such dates. Read SEC document |
| March 15, 2025 Filed Mar 19, 2025 00:45 UTC |
Lin XichenCHIEF SCIENTIFIC OFFICER
|
GrantEmployee Stock Option (right to buy) · Derivative | 196,386 | $0.00 Strike: $7.02 | $0.00 |
DisclosureSEC source: 0001415889-25-008552 · form4-03182025_080306.xml · derivative · entry 2 Lin Xichen · CIK 0001962926 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 196,386 Underlying: Ordinary Shares · 196,386 shares Expires 2035-03-15 F3 · derivative.exercise_price: The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's ADSs. F4 · derivative.exercise_date: 1/4th of the shares subject to the option shall vest March 1, 2026, and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each such vesting date. F1 · derivative.underlying: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ('ADSs"). Each ADS represents three Ordinary Shares of the Issuer. Read SEC document |
| March 15, 2025 Filed Mar 19, 2025 00:45 UTC |
Lin XichenCHIEF SCIENTIFIC OFFICER
|
GrantOrdinary Shares | 80,829 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-008552 · form4-03182025_080306.xml · nonDerivative · entry 1 Lin Xichen · CIK 0001962926 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 166,536 F1 · security: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ('ADSs"). Each ADS represents three Ordinary Shares of the Issuer. F2 · kind: Represents the grant of restricted stock units ("RSUs"), each of which represents a contingent right to receive one ordinary share of the Issuer. The RSUs vest 1/4th annually on each anniversary of March 1, 2025, subject to Reporting Person's continued service on such dates. Read SEC document |
| March 15, 2025 Filed Mar 19, 2025 00:45 UTC |
Yoon JunCHIEF FINANCIAL OFFICER
|
GrantEmployee Stock Option (right to buy) · Derivative | 413,445 | $0.00 Strike: $7.02 | $0.00 |
DisclosureSEC source: 0001415889-25-008551 · form4-03182025_080303.xml · derivative · entry 3 Yoon Jun · CIK 0001962414 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 413,445 Underlying: Ordinary Shares · 413,445 shares Expires 2035-03-14 F4 · derivative.exercise_price: The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's ADSs. F5 · derivative.exercise_date: 1/4th of the shares subject to the option shall vest March 1, 2026, and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each such vesting date. F1 · derivative.underlying: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ('ADSs"). Each ADS represents three Ordinary Shares of the Issuer. Read SEC document |
| March 15, 2025 Filed Mar 19, 2025 00:45 UTC |
Yoon JunCHIEF FINANCIAL OFFICER
|
GrantOrdinary Shares | 170,166 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-008551 · form4-03182025_080303.xml · nonDerivative · entry 1 Yoon Jun · CIK 0001962414 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,293,299 F1 · security: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ('ADSs"). Each ADS represents three Ordinary Shares of the Issuer. F2 · kind: Represents the grant of restricted stock units ("RSUs"), each of which represents a contingent right to receive one Ordinary Share of the Issuer. The RSUs vest 1/4th annually on each anniversary of March 1, 2025, subject to Reporting Person's continued service on such dates. Read SEC document |
| March 01, 2025 Filed Jul 3, 2025 17:15 UTC |
Coll Crespo BlasCHIEF MEDICAL OFFICER
|
Tax withholdingOrdinary Shares | 1,233 | $7.92 | $9,761.17 |
DisclosureSEC source: 0001415889-25-019354 · form4-07032025_050709.xml · nonDerivative · entry 1 Coll Crespo Blas · CIK 0002037144 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 218,355 F1 · security: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents three Ordinary Shares of the Issuer. F2 · shares: Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a restricted share unit award. Read SEC document |
| March 01, 2025 Filed Jul 3, 2025 21:15 UTC |
Stevens Raymond CDirector · CHIEF EXECUTIVE OFFICER
|
Tax withholdingOrdinary Shares | 12,495 | $7.92 | $98,917.92 |
DisclosureSEC source: 0001415889-25-019350 · form4-07032025_050702.xml · nonDerivative · entry 1 Stevens Raymond C · CIK 0001698149 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,121,183 F1 · security: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents three Ordinary Shares of the Issuer. F2 · shares: Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a restricted share unit award. Read SEC document |
| March 01, 2025 Filed Jul 3, 2025 21:15 UTC |
Ma YingliCHIEF TECHNOLOGY OFFICER
|
Tax withholdingOrdinary Shares | 1,824 | $7.92 | $14,439.88 |
DisclosureSEC source: 0001415889-25-019353 · form4-07032025_050708.xml · nonDerivative · entry 1 Ma Yingli · CIK 0001963664 · CHIEF TECHNOLOGY OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 98,715 F1 · security: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents three Ordinary Shares of the Issuer. F2 · shares: Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a restricted share unit award. Read SEC document |
| March 01, 2025 Filed Jul 3, 2025 21:15 UTC |
Lin XichenCHIEF SCIENTIFIC OFFICER
|
Tax withholdingOrdinary Shares | 6,441 | $7.92 | $50,990.82 |
DisclosureSEC source: 0001415889-25-019352 · form4-07032025_050706.xml · nonDerivative · entry 1 Lin Xichen · CIK 0001962926 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 160,095 F1 · security: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents three Ordinary Shares of the Issuer. F2 · shares: Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a restricted share unit award. Read SEC document |
| March 01, 2025 Filed Jul 3, 2025 21:15 UTC |
Yoon JunCHIEF FINANCIAL OFFICER
|
Tax withholdingOrdinary Shares | 5,940 | $7.92 | $47,024.60 |
DisclosureSEC source: 0001415889-25-019351 · form4-07032025_050704.xml · nonDerivative · entry 1 Yoon Jun · CIK 0001962414 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,287,359 F1 · security: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents three Ordinary Shares of the Issuer. F2 · shares: Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a restricted share unit award. Read SEC document |
| February 06, 2025 Filed Feb 10, 2025 13:36 UTC |
FMR LLC10% owner · See Remark 1
|
SaleAmerican Depositary Shares · Derivative | 41 | $30.54 | $1,252.14 |
DisclosureSEC source: 0000950170-25-016705 · ownership.xml · derivative · entry 4 FMR LLC · CIK 0000315066 · 10% owner · See Remark 1 10b5-1 filing: No plan indicated Ownership: Indirect · FIMM, LLC Disclosed balance after: 0 Underlying: Ordinary Shares · 123 shares Expires not disclosed F1 · derivative.exercise_price: Reported securities are American Depositary Shares, each of which represents three Ordinary Shares of the Issuer. Any one American Depositary Share may be converted into three Ordinary Shares, and any three Ordinary Shares into one American Depositary Share, at any time at the election of the holder upon notice. F1 · derivative.exercise_date: Reported securities are American Depositary Shares, each of which represents three Ordinary Shares of the Issuer. Any one American Depositary Share may be converted into three Ordinary Shares, and any three Ordinary Shares into one American Depositary Share, at any time at the election of the holder upon notice. F1 · derivative.expiration_date: Reported securities are American Depositary Shares, each of which represents three Ordinary Shares of the Issuer. Any one American Depositary Share may be converted into three Ordinary Shares, and any three Ordinary Shares into one American Depositary Share, at any time at the election of the holder upon notice. Read SEC document |
| November 20, 2024 Filed Mar 18, 2025 20:45 UTC |
Coll Crespo BlasChief Medical Officer
|
GrantAmerican Depositary Shares · Derivative | 363 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-008555 · form4-03182025_080313.xml · derivative · entry 3 Coll Crespo Blas · CIK 0002037144 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 728 Underlying: Ordinary Shares · 1,089 shares Expires not disclosed F5 · derivative.exercise_price: Each ADS is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The ADSs have no expiration date. F6 · kind: Voluntary reporting of the acquisition of 363 ADSs by the Reporting Person on Novembery 20, 2024 pursuant to the Issuer's Employee Share Purchase Plan. F5 · derivative.exercise_date: Each ADS is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The ADSs have no expiration date. F5 · derivative.expiration_date: Each ADS is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The ADSs have no expiration date. F1 · derivative.underlying: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ('ADSs"). Each ADS represents three Ordinary Shares of the Issuer. Read SEC document |
| November 20, 2024 Filed Mar 19, 2025 00:45 UTC |
Yoon JunCHIEF FINANCIAL OFFICER
|
GrantAmerican Depositary Shares · Derivative | 821 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-008551 · form4-03182025_080303.xml · derivative · entry 5 Yoon Jun · CIK 0001962414 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,115 Underlying: Ordinary Shares · 2,463 shares Expires not disclosed F6 · derivative.exercise_price: Each ADS is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The ADSs have no expiration date. F8 · kind: Voluntary reporting of the acquisition of 821 ADSs by the Reporting Person on Novembery 20, 2024 pursuant to the Issuer's Employee Share Purchase Plan. F6 · derivative.exercise_date: Each ADS is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The ADSs have no expiration date. F6 · derivative.expiration_date: Each ADS is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The ADSs have no expiration date. F1 · derivative.underlying: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ('ADSs"). Each ADS represents three Ordinary Shares of the Issuer. Read SEC document |
| September 18, 2024 Filed Sep 20, 2024 17:42 UTC |
Coll Crespo BlasChief Medical Officer
|
GrantShare option (right to buy) · Derivative | 111,000 | $0.00 Strike: $12.75 | $0.00 |
DisclosureSEC source: 0001415889-24-023791 · form4-09202024_090935.xml · derivative · entry 2 Coll Crespo Blas · CIK 0002037144 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 111,000 Underlying: Ordinary Shares · 111,000 shares Expires 2034-09-17 F3 · derivative.exercise_price: The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's ADSs. F4 · derivative.exercise_date: One-fourth of the shares vest on the first anniversary of September 18, 2024, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter. F1 · derivative.underlying: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ('ADSs"). Each ADS represents three Ordinary Shares of the Issuer. Read SEC document |
| September 18, 2024 Filed Sep 20, 2024 17:42 UTC |
Coll Crespo BlasChief Medical Officer
|
GrantOrdinary Shares | 90,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-023791 · form4-09202024_090935.xml · nonDerivative · entry 1 Coll Crespo Blas · CIK 0002037144 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,600 F1 · security: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ('ADSs"). Each ADS represents three Ordinary Shares of the Issuer. F2 · shares: Represents restricted stock unit award granted under the Issuer's 2023 Equity Incentive Plan. Read SEC document |
| September 18, 2024 Filed Sep 20, 2024 17:47 UTC |
Hall AshleyChief Development Officer
|
GrantShare option (right to buy) · Derivative | 82,890 | $0.00 Strike: $12.75 | $0.00 |
DisclosureSEC source: 0001415889-24-023794 · form4-09202024_090932.xml · derivative · entry 2 Hall Ashley · CIK 0001801842 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 82,890 Underlying: Ordinary Shares · 82,890 shares Expires 2034-09-17 F3 · derivative.exercise_price: The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's ADSs. F4 · derivative.exercise_date: One-fourth of the shares vest on the first anniversary of September 18, 2024, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter. F1 · derivative.underlying: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents three Ordinary Shares of the Issuer. Read SEC document |
| September 18, 2024 Filed Sep 20, 2024 17:47 UTC |
Hall AshleyChief Development Officer
|
GrantOrdinary Shares | 67,290 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-023794 · form4-09202024_090932.xml · nonDerivative · entry 1 Hall Ashley · CIK 0001801842 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,290 F1 · security: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents three Ordinary Shares of the Issuer. F2 · shares: Represents restricted stock unit award granted under the Issuer's 2023 Equity Incentive Plan. Read SEC document |
| August 26, 2024 Filed Aug 28, 2024 20:37 UTC |
Russell Angus C.Director
|
GrantShare option (right to buy) · Derivative | 75,000 | $0.00 Strike: $13.53 | $0.00 |
DisclosureSEC source: 0001415889-24-022457 · form4-08282024_080826.xml · derivative · entry 1 Russell Angus C. · CIK 0001534002 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,000 Underlying: Ordinary Shares · 75,000 shares Expires 2034-08-25 F1 · derivative.exercise_price: The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's American Depositary Shares ("ADSs"). F2 · derivative.exercise_date: The shares vest in equal monthly installments over a three-year period such that the option is fully vested on the third anniversary of August 26, 2024. F3 · derivative.underlying: The Ordinary Shares of the Issuer may be represented by ADSs. Each ADS represents three Ordinary Shares of the Issuer. Read SEC document |
| June 25, 2024 Filed Jun 27, 2024 20:15 UTC |
WELCH DANIEL GDirector
|
GrantShare Option (right to buy) · Derivative | 37,500 | $0.00 Strike: $13.32 | $0.00 |
DisclosureSEC source: 0001415889-24-018324 · form4-06272024_040601.xml · derivative · entry 1 WELCH DANIEL G · CIK 0001206199 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,500 Underlying: Ordinary Shares · 37,500 shares Expires 2034-06-24 F1 · derivative.exercise_price: The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's American Depositary Shares ("ADSs"). F2 · derivative.exercise_date: The shares vest in equal monthly installments over the 12 months following June 25, 2024. F3 · derivative.underlying_shares: The Ordinary Shares of the Issuer may be represented by ADSs. Each ADS represents three Ordinary Shares of the Issuer. Read SEC document |
| June 25, 2024 Filed Jun 27, 2024 20:15 UTC |
LOVE TED WDirector
|
GrantShare Option (right to buy) · Derivative | 33,595 | $0.00 Strike: $13.32 | $0.00 |
DisclosureSEC source: 0001415889-24-018328 · form4-06272024_040609.xml · derivative · entry 1 LOVE TED W · CIK 0001188919 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,595 Underlying: Ordinary Shares · 33,595 shares Expires 2034-06-24 F1 · derivative.exercise_price: The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's American Depositary Shares ("ADSs"). F2 · derivative.exercise_date: The shares vest in equal monthly installments over the 12 months following June 25, 2024. F3 · derivative.underlying_shares: The Ordinary Shares of the Issuer may be represented by ADSs. Each ADS represents three Ordinary Shares of the Issuer. Read SEC document |
| June 25, 2024 Filed Jun 27, 2024 20:15 UTC |
DOBMEIER ERICDirector
|
GrantShare Option (right to buy) · Derivative | 37,500 | $0.00 Strike: $13.32 | $0.00 |
DisclosureSEC source: 0001415889-24-018326 · form4-06272024_040605.xml · derivative · entry 1 DOBMEIER ERIC · CIK 0001202785 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,500 Underlying: Ordinary Shares · 37,500 shares Expires 2034-06-24 F1 · derivative.exercise_price: The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's American Depositary Shares ("ADSs"). F2 · derivative.exercise_date: The shares vest in equal monthly installments over the 12 months following June 25, 2024. F3 · derivative.underlying_shares: The Ordinary Shares of the Issuer may be represented by ADSs. Each ADS represents three Ordinary Shares of the Issuer. Read SEC document |
| June 25, 2024 Filed Jun 27, 2024 20:15 UTC |
TETLOW SHARONDirector
|
GrantShare Option (right to buy) · Derivative | 37,500 | $0.00 Strike: $13.32 | $0.00 |
DisclosureSEC source: 0001415889-24-018325 · form4-06272024_040603.xml · derivative · entry 1 TETLOW SHARON · CIK 0001328565 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,500 Underlying: Ordinary Shares · 37,500 shares Expires 2034-06-24 F1 · derivative.exercise_price: The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's American Depositary Shares ("ADSs"). F2 · derivative.exercise_date: The shares vest in equal monthly installments over the 12 months following June 25, 2024. F3 · derivative.underlying_shares: The Ordinary Shares of the Issuer may be represented by ADSs. Each ADS represents three Ordinary Shares of the Issuer. Read SEC document |
| June 25, 2024 Filed Jun 27, 2024 20:15 UTC |
Waldstreicher JoanneDirector
|
GrantShare Option (right to buy) · Derivative | 37,500 | $0.00 Strike: $13.32 | $0.00 |
DisclosureSEC source: 0001415889-24-018327 · form4-06272024_040607.xml · derivative · entry 1 Waldstreicher Joanne · CIK 0001962413 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,500 Underlying: Ordinary Shares · 37,500 shares Expires 2034-06-24 F1 · derivative.exercise_price: The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's American Depositary Shares ("ADSs"). F2 · derivative.exercise_date: The shares vest in equal monthly installments over the 12 months following June 25, 2024. F3 · derivative.underlying_shares: The Ordinary Shares of the Issuer may be represented by ADSs. Each ADS represents three Ordinary Shares of the Issuer. Read SEC document |
| June 12, 2024 Filed Jun 15, 2024 00:19 UTC |
Stevens Raymond CDirector · CHIEF EXECUTIVE OFFICER
|
Exercise / conversionShare Option (right to buy) · Derivative | 50,001 | $0.00 Strike: $0.48 | $0.00 |
DisclosureSEC source: 0001415889-24-017040 · form4-06152024_120647.xml · derivative · entry 5 Stevens Raymond C · CIK 0001698149 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 488,766 Underlying: Ordinary Shares · 50,001 shares Expires 2031-01-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The shares vest in a series of 48 successive equal monthly installments beginning one month after January 22, 2021. Read SEC document |
| June 12, 2024 Filed Jun 15, 2024 00:19 UTC |
Stevens Raymond CDirector · CHIEF EXECUTIVE OFFICER
|
Exercise / conversionShare Option (right to buy) · Derivative | 99,999 | $0.00 Strike: $0.39 | $0.00 |
DisclosureSEC source: 0001415889-24-017040 · form4-06152024_120647.xml · derivative · entry 4 Stevens Raymond C · CIK 0001698149 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1 Underlying: Ordinary Shares · 99,999 shares Expires 2030-01-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 12, 2024 Filed Jun 15, 2024 00:19 UTC |
Stevens Raymond CDirector · CHIEF EXECUTIVE OFFICER
|
Exercise / conversionOrdinary Shares | 50,001 | $0.48 | $24,000.48 |
DisclosureSEC source: 0001415889-24-017040 · form4-06152024_120647.xml · nonDerivative · entry 2 Stevens Raymond C · CIK 0001698149 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 793,346 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 12, 2024 Filed Jun 15, 2024 00:19 UTC |
Stevens Raymond CDirector · CHIEF EXECUTIVE OFFICER
|
Exercise / conversionOrdinary Shares | 99,999 | $0.39 | $38,999.61 |
DisclosureSEC source: 0001415889-24-017040 · form4-06152024_120647.xml · nonDerivative · entry 1 Stevens Raymond C · CIK 0001698149 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 743,345 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 10, 2024 Filed Jun 12, 2024 20:42 UTC |
Stevens Raymond CDirector · CHIEF EXECUTIVE OFFICER
|
SaleAmerican Depositary Shares · Derivative | 185,000 | $52.80 | $9,767,352.50 |
DisclosureSEC source: 0001415889-24-016510 · form4-06122024_080615.xml · derivative · entry 4 Stevens Raymond C · CIK 0001698149 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 555,000 shares Expires not disclosed F3 · derivative.exercise_price: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. F4 · price: The weighted average sale price for the transaction was $52.7965, and the range of prices was $52.43 and $53.075. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. F3 · derivative.exercise_date: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. F3 · derivative.expiration_date: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. Read SEC document |
| June 10, 2024 Filed Jun 12, 2024 20:42 UTC |
Stevens Raymond CDirector · CHIEF EXECUTIVE OFFICER
|
ConversionAmerican Depositary Shares · Derivative | 185,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-016510 · form4-06122024_080615.xml · derivative · entry 3 Stevens Raymond C · CIK 0001698149 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 185,000 Underlying: Ordinary Shares · 555,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. F3 · derivative.exercise_date: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. F3 · derivative.expiration_date: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. Read SEC document |
| June 10, 2024 Filed Jun 12, 2024 20:42 UTC |
Stevens Raymond CDirector · CHIEF EXECUTIVE OFFICER
|
ConversionOrdinary Shares | 555,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-016510 · form4-06122024_080615.xml · nonDerivative · entry 1 Stevens Raymond C · CIK 0001698149 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 643,346 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The Ordinary Shares were converted into American Depositary Shares as reported in Table II above. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 23:38 UTC |
Lin XichenCHIEF SCIENTIFIC OFFICER
|
SaleAmerican Depositary Shares · Derivative | 17,700 | $50.00 | $885,070.80 |
DisclosureSEC source: 0001415889-24-015683 · form4-06052024_110646.xml · derivative · entry 6 Lin Xichen · CIK 0001962926 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 53,100 shares Expires not disclosed F4 · derivative.exercise_price: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. F6 · shares: The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on December 28, 2023. F7 · price: The weighted average sale price for the transaction reported was $50.004, and the range of prices were between $50.00 and $50.16. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided. F4 · derivative.exercise_date: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. F4 · derivative.expiration_date: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 23:38 UTC |
Lin XichenCHIEF SCIENTIFIC OFFICER
|
SaleAmerican Depositary Shares · Derivative | 17,700 | $45.00 | $796,500.00 |
DisclosureSEC source: 0001415889-24-015683 · form4-06052024_110646.xml · derivative · entry 5 Lin Xichen · CIK 0001962926 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 17,700 Underlying: Ordinary Shares · 53,100 shares Expires not disclosed F4 · derivative.exercise_price: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. F6 · shares: The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on December 28, 2023. F4 · derivative.exercise_date: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. F4 · derivative.expiration_date: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 23:38 UTC |
Lin XichenCHIEF SCIENTIFIC OFFICER
|
ConversionAmerican Depositary Shares · Derivative | 35,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-015683 · form4-06052024_110646.xml · derivative · entry 4 Lin Xichen · CIK 0001962926 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 35,400 Underlying: Ordinary Shares · 106,200 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. F5 · shares: 106,200 Ordinary Shares, which were acquired upon exercise of a share option, were converted into 35,400 American Depositary Shares. F4 · derivative.exercise_date: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. F4 · derivative.expiration_date: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.